Jeito Capital
Parisjeito.life
Overview
Jeito Capital is a leading global independent private equity firm dedicated to the biopharma sector that finances and accelerates breakthrough medical innovation.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Bionyra Pharma | Jun 2026 | Series A | Lead |
| Adcendo | Apr 2026 | Series C | Lead |
| Alveus Therapeutics | Feb 2026 | Series A Extension | Co-investor |
| Odyssey Therapeutics | Sep 2025 | Series D | Co-investor |
| ReproNovo | May 2025 | Series A | Lead |
Key People
Rafaèle Tordjman
Founder CEO
Sabine Dandiguian
Managing Partner
Pascal Touchon
Operating Partner
Ksenija Pavletic
Partner Investor, CCO
Daniel Wolle
Principal
Julien ELRIC
Senior Principal
Mehdi AINOUCHE
Senior Principal
Annette Clancy
Operational Investor
Rachel Mears
Investor - Life Sciences
Claudio Costa-Neto
Chief Scientific Officer
Julie Darbellay
Investor Relations Jeito
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
